CLOV Earnings & Financial Statements
Clover Health Investments, Corp.
$4.79
-$0.02(-0.42%)
60
Overall
60
Value
63
Tech
57
Quality
Market Cap
$2.54B
Volume
3.73M
52W Range
$1.58 - $5.59
Target Price
$5.30
CLOV earnings and financial statements: Clover Health Investments, Corp.'s income statement, balance sheet and cash flow statement, annual and quarterly.
CLOV Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $1.92B | $1.37B | $1.26B | $3.48B | $1.47B |
| Cost of revenue | $1.57B | $1.01B | $1.78B | $3.45B | $1.55B |
| Operating income | -$85.53M | -$45.75M | -$205.33M | -$371.65M | -$636.99M |
| EBITDA | -$85.71M | -$47.46M | -$211.65M | -$336.99M | -$569.60M |
| Net income | -$85.55M | -$43.01M | -$213.36M | -$339.57M | -$587.76M |
| EPS (diluted) | $-0.17 | $-0.08 | $-0.44 | $-0.71 | $-1.42 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $541.01M | $580.74M | $570.67M | $808.62M | $950.80M |
| Total liabilities | $232.31M | $239.60M | $284.28M | $451.73M | $411.49M |
| Shareholders’ equity | $308.65M | $341.09M | $286.35M | $356.88M | $535.41M |
| Cash and equivalents | $78.30M | $194.54M | $116.41M | $103.79M | $299.97M |
| Long-term debt | - | - | $3.00M | $4.03M | $24.77M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$66.93M | $34.84M | -$144.66M | -$203.93M | -$282.33M |
| Capital expenditure | -$2.04M | -$1.56M | -$584.0K | -$4.47M | -$723.0K |
| Free cash flow | -$68.98M | $33.29M | -$145.25M | -$208.39M | -$283.05M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CLOV | $4.79 | -0.4% | 3.73M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Clover Health Investments, Corp. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW